Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance

Christian Lienhardt and colleagues discuss the importance of communication and coordination between regulators, researchers, and policy makers to ensure tuberculosis trials provide high-quality evidence for policy decisions.

Detalles Bibliográficos
Autores principales: Lienhardt, Christian, Vernon, Andrew A., Cavaleri, Marco, Nambiar, Sumati, Nahid, Payam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Collection Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730844/
https://www.ncbi.nlm.nih.gov/pubmed/31490921
http://dx.doi.org/10.1371/journal.pmed.1002915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730844/
https://www.ncbi.nlm.nih.gov/pubmed/31490921
http://dx.doi.org/10.1371/journal.pmed.1002915

Ejemplares similares